Helen Collins

Chief Tech/Sci/R&D Officer at ENLIVEN THERAPEUTICS, INC.

Net worth: 1 M $ as of 29/06/2026

63 year

34 connections

Health Technology

Consumer Services

Health Services

Profile

Helen Collins is the founder of North Bay Cancer Alliance, Inc., founded in 2005.
Current jobs include Independent Director at Kura Oncology, Inc. since 2021 and Chief Medical Officer at Enliven Therapeutics, Inc. since 2023.
Former jobs include Independent Director at IO Biotech, Inc. from 2023 to 2026; Chief Medical Officer & Executive Vice President at Five Prime Therapeutics, Inc. from 2019 to 2021; President at Redwood Regional Medical Group, Inc. from 2006 to 2009; Lead Global Head-Oncology Biosimilars at Amgen, Inc.; and Head-Lead Clinical & Program at Gilead Sciences, Inc. Education includes an undergraduate degree from Bryn Mawr College in 1984 and a doctorate from The Johns Hopkins University School of Medicine.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ENLIVEN THERAPEUTICS, INC. 0.03%	16/06/2026	25,000 ( 0.03% )	1 M $	29/06/2026
KURA ONCOLOGY, INC. -.--%	03/06/2026	0 ( -.--% )	- $	29/06/2026

Helen Collins active positions

Companies	Position	Start
KURA ONCOLOGY, INC.	Director/Board Member	28/07/2021
ENLIVEN THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	22/02/2023

All active positions of Helen Collins

Former positions of Helen Collins

Companies	Position	End
IO BIOTECH, INC.	Director/Board Member	30/03/2026
FIVE PRIME THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	15/04/2021
Redwood Regional Medical Group, Inc. Redwood Regional Medical Group, Inc. Medical/Nursing ServicesHealth Services Provides medical radiology, oncology, orthopedics, and surgey services	President	31/12/2008
AMGEN INC.	Corporate Officer/Principal	-
GILEAD SCIENCES, INC.	Corporate Officer/Principal	-

See the detail of Helen Collins's experience

Training of Helen Collins

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Helen Collins's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
Gilead Sciences, Inc. Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases	Health Technology
Five Prime Therapeutics, Inc. Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases	Health Technology
Kura Oncology, Inc. Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company	Health Technology
Bryn Mawr College Bryn Mawr College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Redwood Regional Medical Group, Inc. Redwood Regional Medical Group, Inc. Medical/Nursing ServicesHealth Services Provides medical radiology, oncology, orthopedics, and surgey services	Health Services
The Johns Hopkins University School of Medicine The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
North Bay Cancer Alliance, Inc. North Bay Cancer Alliance, Inc. Miscellaneous Commercial ServicesCommercial Services Provides individual and family social services	Commercial Services
IO Biotech, Inc. IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies	Health Technology
Enliven Therapeutics, Inc. Enliven Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage precision oncology company that develops molecule therapies	Health Technology